mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.02 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |